Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
CardiovascularORALStandard

ATORVALIQ

ATORVASTATIN CALCIUM

Standard Dose
20MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ATORVALIQ is listed in Drugs@FDA under application 213260 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ATORVASTATIN CALCIUM Form and strength SUSPENSION;ORAL - 20MG/5ML Sponsor CMP DEV LLC Submission history Latest submission status date: 2024-04-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview ATORVALIQ is listed in Drugs@FDA under application 213260 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ATORVASTATIN CALCIUM Form and strength SUSPENSION;ORAL - 20MG/5ML Sponsor CMP DEV LLC Submission history Latest submission status date: 2024-04-23 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.